AG¡¤×ðÁú¿­Ê± - ÈËÉú¾ÍÊDz«!

ÈÕ±¾ÕZ
ÐÂÎÅÖÐÐÄ

11/4

2024

º£ºÍÒ©ÎïÓëÖÇÇæ´ï³É×Ïɼ´¼¿Ú·þÈÜÒº£¨RMX3001£¬LIPORAXEL®£©Öйų́ÍåµØÇø¶À¼Ò¾­ÏúЭÒé

½ñÈÕ£¬º£ºÍÒ©ÎïÐû²¼£¬ÉϺ£º£ºÍÒ©ÎïÑо¿¿ª·¢¹É·ÝÓÐÏÞ¹«Ë¾Ö®¿Ø¹É×Ó¹«Ë¾ÅµÂõÎ÷£¨ÉϺ££©Ò½Ò©¿Æ¼¼ÓÐÏÞ¹«Ë¾ÓëÖÇÇæÓÚ½ñÈÕÍê³ÉÇ©Êð×Ïɼ´¼¿Ú·þÈÜÒº£¨LIPORAXEL®£©Ò©Æ·Ö®¾­ÏúºÏÔ¼£¬ÖÇÇ湫˾ΪLIPORAXEL®ÔÚÖйų́ÍåÖ®¶À¼Ò¾­ÏúÉÌ£¬¸ºÔðÉêÇëÐÂÒ©²éÑéµÇ¼Ç£¨NDA£©¼°ºóÐøÊг¡Íƹ㼰ÏúÊÛµÈÒµÎñ¡£

 

LIPORAXEL®Îªº«¹úDaehwa Pharmaceutical Co., Ltd.ËùÑз¢ÖÆÔìÖ®×Ïɼ´¼¿Ú·þÖƼÁ£¬ÉϺ£ÅµÂõÎ÷¹«Ë¾ÓÚ2017Äê9Ôºͺ«¹úDaehwaÇ©ÊðÊÚȨÆõÔ¼¡£2024Äê9Ô£¬×Ïɼ´¼¿Ú·þÈÜÒº(Ñз¢´úºÅ£ºRMX3001)»ñµÃÖйú¹ú¼ÒÒ©Æ·¼à¶½¹ÜÀí¾Ö£¨NMPA£©Åú×¼ÔÚÖйú´ó½ÉÏÊУ»ÓÃÓÚÒ»Ïߺ¬·úÄòà×à¤Àà·½°¸ÖÎÁÆÆÚ¼ä»òÖÎÁƺó³öÏÖ¼²²¡½øÕ¹µÄÍíÆÚθ°©»¼ÕßµÄÖÎÁÆ¡£

 
º£ºÍÒ©ÎïÊ×ϯִÐйٶ­Èðƽ²©Ê¿±íʾ£º
“×Ïɼ´¼¿Ú·þÈÜÒº×÷ΪȫÇòµÚÒ»¸ö¿ª·¢³É¹¦²¢»ñÅúÉÏÊеĿڷþ¼ÁÐÍ×Ïɼ´¼ÀàÒ©ÎÔÚÁÙ´²Ñо¿ÖÐÕ¹ÏÖ³öÏÔÖøµÄÉú´æ»ñÒæºÍÁ¼ºÃµÄÄÍÊÜÐÔ¡£Ï£ÍûÔÚº£ºÍÒ©Îï¼°ÆäºÏ×÷»ï°é——ÖÇÇ湫˾¹²Í¬Å¬Á¦Ï£¬Ô츣¸ü¶àµÄÖ×Áö»¼Õß¡£”
 
ÖÇÇæ×ܾ­ÀíÍõºêÈʱíʾ£º
“LIPORAXEL®ÊÇÀûÓô´ÐµÄÒ©ÎïµÝËͼ¼Êõ£¬½«Êг¡ÉÏ´«Í³Ê¹Óõľ²Âö×¢Éä×Ïɼ´¼¼ÁÐÍ (IV paclitaxel)£¬¿ª·¢¶ø³É×Ïɼ´¼¿Ú·þÖƼÁ¡£LIPORAXEL®¿Ú·þÖƼÁ¿ÉÒÔÌṩÁÙ´²ÉÏʹÓõķ½±ãÐÔ£¬ÆÚÍûÓÐÖúÓÚÌáÉý²¡»¼µÄÉú»îÖÊÁ¿¡£ÖÇÇæ³ýÁ˳ÖÐøרעÔÚ°©Ö¢´´ÐÂÒ©Ñз¢ÁìÓòÉÏ£¬Ò²³ÖÐø¹Ø×¢»¼ÕßÐèÇó£¬Òý½ø´´ÐÂÒ©Æ·£¬ÒÔÌṩ²¡»¼¸ü¶àµÄÖÎÁÆÑ¡Ôñ¡£”
 
¹ØÓÚ×Ïɼ´¼¿Ú·þÈÜÒº£¨Ñз¢´úºÅ£ºRMX3001/DHP107£©

×Ïɼ´¼ÊÇÓ¦ÓÃ×îΪ¹ã·ºµÄ»¯ÁÆÒ©ÎïÖ®Ò»£¬Êг¡ÐèÇó¾Þ´ó¡£Ä¿Ç°¹úÄÚ¸ÃÒ©ÎïµÄÉÏÊмÁÐ;ùΪעÉä¼Á £¬Ðè¾­ÅäÖƺóÔÚÒ½Ôº¾­¾²ÂöµÎ×¢¸øÒ©£¬»¼ÕßÐèƵ·±·µÔº£¬ÇÒ»áÓÐ×¢É䲿λ²»Á¼·´Ó¦£¬Òò´Ë¿Ú·þ×Ïɼ´¼ÖƼÁµÄ¿ª·¢Ò»Ö±ÊÇÐÐÒµÑо¿µÄÈȵã¡£¸Ã²úÆ·ÊÇÓÉ´ó»¯ÖÆÒ©»ùÓÚÆ䴴еÄÖ¬ÖÊ×ÔÈ黯ҩÎïµÝËͼ¼Êõ¿ª·¢¶ø³ÉµÄ×Ïɼ´¼¿Ú·þÖƼÁ£¬ÓÚ2016Äê9ÔÂ9Èճɹ¦»ñµÃº«¹úÒ©¼à»ú¹¹£¨MFDS£©µÄÉÏÊÐÅú×¼£¬ÊÊӦ֢ΪÍíÆÚ»òתÒÆÐÔθ°©»ò¾Ö²¿¸´·¢ÐÔθ°©¶þÏßÖÎÁÆ¡£½ØֹĿǰ£¬RMX3001ÊÇÈ«ÇòµÚÒ»¸ö¿ª·¢³É¹¦²¢»ñÅúÉÏÊеĿڷþ×Ïɼ´¼²úÆ·¡£º£ºÍÒ©ÎïÓÚ2017Äê9Ô´Ӵó»¯ÖÆÒ©»ñµÃ¸Ã²úÆ·µÄÖйú´ó½¡¢Ì¨Íå¡¢Ïã¸Û¼°Ì©¹úÑз¢¡¢Éú²ú¼°ÏúÊÛȨÒæ¡£

¹ØÓÚAG¡¤×ðÁú¿­Ê± - ÈËÉú¾ÍÊDz«!

º£ºÍÒ©ÎïÊÇÖйúÁìÏȵÄ×ÔÖ÷´´ÐÂÉúÎï¼¼Êõ¹«Ë¾£¬×¨×¢ÓÚ¿¹Ö×Áö´´ÐÂÒ©ÎïµÄ·¢ÏÖ¡¢¿ª·¢¡¢Éú²ú¼°ÉÌÒµ»¯£¬Ï£ÍûΪȫÇò°©Ö¢»¼Õß´øÀ´¸ü°²È«¡¢¸üÓÐЧµÄÖÎÁÆ·½·¨¡£º£ºÍÒ©Îï¼á³Ö×ß×ÔÖ÷´´ÐµĵÀ·£¬Í¬Ê±ÓµÓÐÒ»Ö§¾ßÓÐÈ«Çò»¯ÊÓÒ°µÄ¿ÆÑк͹ÜÀíÍŶÓ£¬»ý¼«²¼¾Ö´´ÐÂÒ©ÎïµÄ¹ú¼Ê¿ª·¢Ö®Â·¡£Ä¿Ç°º£ºÍÒ©ÎïÒÑÓÐ2¿î²úÆ·»ñ×¼ÉÏÊУº1.¹ÈÃÀÌæÄáƬ£¬ÖÐÎÄÉÌÆ·Ãû£ºº£Òæ̹®£¬ÈÕ±¾ÉÌÆ·Ãû£º¥Ï¥¤¥¤©`¥¿¥ó®åV50©J£¬ÒÑÕýʽÔÚÖйúºÍÈÕ±¾¾ù»ñÅúÉÏÊУ»2.×Ïɼ´¼¿Ú·þÈÜÒºÒÑÕýʽÔÚÖйú»ñÅúÉÏÊС£Áí£¬º£ºÍÒ©ÎïͬʱÓжà¸öÔÚÑÐÖصã¹ÜÏߵĺòÑ¡Ò©Îï¡£

¹ØÓÚÖÇÇæÉú¼¼ÖÆÒ©¹É·ÝÓÐÏÞ¹«Ë¾

ÖÇÇæ³ÉÁ¢ÓÚ2003Ä꣬²É¹ú¼Ê²ßÂÔÁªÃ˼° "Virtual Pharmaceutical Company Business Model" Ö®ÓªÔËģʽ£¬ÖÂÁ¦ÓÚ°©Ö¢ÐÂÒ©Ñз¢¡£ÖÇÇæÒÑÉÌÒµ»¯Ö®²úÆ·°²Äܵî (ONIVYDE®)£¬ÒѺË×¼ÓÃÓÚÒÈÏÙ°©³ÉÈ˲¡»¼µÄÖÎÁÆ£¬ÓÚÃÀ¹ú¡¢Å·ÖÞ¼°ÑÇÖÞµÈÈ«Çò¶à¸öÖ÷Òª¹ú¼ÒÉÏÊС£ÁíÖÇÇ滹ÓжàÏî°©Ö¢ÐÂÒ©ÏîÄ¿ÔÚ·¢Õ¹ÖС£

ÖÇÇæÉú¼¼·¢ÑÔÈË£ºÕÅ÷èÐÇ ¸±×ܾ­Àí (info@pharmaengine.com)

| ·¨ÂÉÉùÃ÷ | ÃâÔðÉùÃ÷ | ÁªÏµÎÒÃÇ | Ò½Ò©´ú±í±¸°¸¹«Ê¾ |
¹Ø×¢ÎÒÃÇ
?2020 ÉϺ£º£ºÍÒ©ÎïÑо¿¿ª·¢¹É·ÝÓÐÏÞ¹«Ë¾
°æȨËùÓÐ »¦ICP±¸12016151ºÅ-1
¡¾ÍøÕ¾µØͼ¡¿¡¾sitemap¡¿
ÓÑÇéÁ´½Ó£ºÈËÉú¾ÍÊDz©¡¤(ÖйúÇø)¹Ù·½ÍøÕ¾  ×ðÁú¿­Ê±ÈËÉú¾ÍÊDz«¡¤¡¸ÖйúÇø¡¹°Ù¶È°Ù¿Æ  Z6¡¤×ðÁú¿­Ê±¡¸Öйú¡¹¹Ù·½ÍøÕ¾  ×ðÁú¿­Ê±¡¸ÖйúÇø¡¹ÈËÉú¾ÍÊDz«!  ÈËÉú¾ÍÊDz©¡¤(Öйú´ó½) - ¹Ù·½ÍøÕ¾  ÈËÉú¾ÍÊDz©¡¤(Öйú´ó½) - ¹Ù·½ÍøÕ¾  Z6¡¤×ðÁú¿­Ê±¡¸Öйú¡¹¹Ù·½ÍøÕ¾  ×ðÁú¿­Ê±ÈËÉú¾ÍÊDz«¡¤(ÖйúÇø)¹Ù·½ÍøÕ¾